drug

Pindolol Viatris

Marketedupdated 3mo ago

by Mylan Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Pindolol Viatris

phase2A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)recruitingn=120
phase1Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)completedn=51

News(1)

Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
Actimed Therapeutics has brought the full rights to its wasting disease drug back in-house, securing “strategic control” over the asset but losing out on a shot at over $120 million in biobucks.
fiercebiotech · 9d ago

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Pindolol Viatris

Marketedupdated 3mo ago

by Mylan Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Pindolol Viatris

News(1)

Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
Actimed Therapeutics has brought the full rights to its wasting disease drug back in-house, securing “strategic control” over the asset but losing out on a shot at over $120 million in biobucks.
fiercebiotech · 9d ago

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Pindolol Viatris

all catalysts(0)

Trials studying Pindolol Viatris

News(1)

Report a data issue

comments(0)

Pindolol Viatris

all catalysts(0)

Trials studying Pindolol Viatris

News(1)

Report a data issue

comments(0)